Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
A short and divergent route towards new derivatives of 2-(trifluoromethyl)pyridines as potent inverse agonists of the bacterial target PqsR against Pseudomonas aeruginosa (PA) infections is described. This Gram-negative pathogen causes severe nosocomial infections and common antibiotic treatment options are rendered ineffective due to resistance issues. Based on an earlier identified optimized hit, we conducted derivatization and rigidification attempts employing two central building blocks. The western part of the molecule is built up via a 2-(trifluoromethyl)pyridine head group equipped with a terminal alkyne. The eastern section is then introduced through aryliode motifs exploiting Sonogashira as well as Suzuki-type chemistry. Subsequent modification provided quick access to an array of compounds, allowed for deep SAR insights, and enabled to optimize the hit scaffold into a lead structure of nanomolar potency combined with favorable in vitro ADME/T features.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2021.113797 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification and Validation of Inverse Agonists for Nuclear Receptor Subfamily 4 Group A Member 2.
ACS Omega
September 2025
Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, 116021 Dalian, China.
Former studies indicate that nuclear receptor subfamily 4 group A member 2 (Nurr1, NR4A2), a transcription factor, is regarded as a potential therapeutic target for central nervous system diseases, and many studies have focused on the development and optimization of agonists of Nurr1. Recent studies have shown that Nurr1 is upregulated in many other diseases. However, there is still a lack of effective inverse Nurr1 agonists as a therapeutic strategy or as pharmacological tools to counteract the receptor's inherent activity.
View Article and Find Full Text PDFReal-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder.
Clinicoecon Outcomes Res
August 2025
AbbVie, North Chicago, IL, USA.
Purpose: Major depressive disorder (MDD) is a disabling condition that may require adjunctive treatment with atypical antipsychotics (AAs). However, little is known about how different adjunctive AAs impact disability outcomes. This analysis compared disability events, days, and costs among patients with MDD before and after initiating adjunctive treatment with cariprazine, brexpiprazole, or aripiprazole, which all belong to a class of AAs known as dopamine partial agonists.
View Article and Find Full Text PDFUnveiling G protein-coupled inwardly-rectifying potassium channel 4 (GIRK4) inverse agonists: A novel simulation-driven approach leveraging cellular ion flow coupled with chemometrics and protein conformational dynamics.
Int J Biol Macromol
August 2025
Drug Discovery and Development Laboratory (DDD Lab), Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Electronic address:
GIRK channels are crucial in regulating cardiac excitability and present promising therapeutic targets. Notably, the genetic absence of GIRK4 prevents atrial fibrillation (AF) in knockout mice, yet research on specific GIRK4 modulators is limited. Addressing the challenges posed by GIRK4's intrinsic constitutive activity, we hypothesize that a GIRK inverse agonist unlike the traditional antagonist can actively downregulate the channel activity alongside reduction of the aberrant basal signaling which can translate to enhanced therapeutic efficacy.
View Article and Find Full Text PDFSerotonin type 6 receptor inverse agonists and neutral antagonists inhibit defecation: relevance to intestinal motility disorders.
Eur J Pharmacol
August 2025
Department of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
The serotonergic system plays a crucial role in numerous physiological processes in the central and peripheral nervous systems. In the gastrointestinal (GI) tract, serotonin has been implicated in the control of motility and visceral pain associated with irritable bowel syndrome (IBS). Here, we investigated the impact of blocking differently activated conformational states of the type 6 serotonin receptor (5-HT) upon intestinal motility and diarrhea in both non-stressed and stressed mice.
View Article and Find Full Text PDFHistamine H1 receptor inverse agonists improve structure and pain in an osteoarthritis mouse model.
J Clin Invest
August 2025
Department of Molecular and Cellular Biology, Scripps Research, La Jolla, United States of America.
Osteoarthritis (OA) is the most common joint disease. Controlling the complex pathogenesis is challenging, thus disease-modifying OA drugs are not available. Forkhead box O (FOXO) transcription factors contribute to cartilage homeostasis through autophagy and oxidative stress resistance.
View Article and Find Full Text PDF